Drawing for HT

USPTO serial 79156577

HT

Reviewed by CopyMark Law Group

Reg. 4829452Status 404
Filing date
Status date
Registration date
Oct 13, 2015
Examiner
I, DAVID C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle Levin

Michelle Levin Leason Ellis LLPOne Barker Avenue, Fifth FloorWhite Plains, NY 10601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Medical analysis for the diagnosis and treatment of persons; providing information in the field of medicine; medical counseling; medical information; providing on-line information relating to the prevention of cardiovascular disease and strokes; provision of medical information; conducting screenings for cardiovascular disease risk factors; medical analysis services relating to the treatment of persons; medical analysis services relating to the treatment of patients; advisory services relating to cardiovascular disease, stroke, and medical conditions associated with autonomic nervous system; medical services; medical information services provided via the Internet; medical screening services relating to cardiovascular disease; medical testing for diagnosing cardiovascular disease, stroke, and medical conditions associated with autonomic nervous system; conducting of medical examinations for insurance purposes; medical consultations; consulting in the field of medical care; health counseling; health consultancy; provision of health information; medical screening; Providing medical diagnostic services, namely, diagnostic testing for diagnosing cardiovascular disease, stroke, and medical conditions associated with autonomic nervous system; medical examination services for insurance purposes; medical testing services for the diagnosis and treatment of disease; medical care and analysis services, namely, services for cardiovascular disease, stroke, and medical conditions associated with autonomic nervous system, relating to patient treatment; individual medical counseling services provided to patientsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 8, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 8, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 20, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 21, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 21, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 29, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 29, 2022C71TCANCELLED SECTION 71—
Oct 13, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 1, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 16, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 16, 2016FIMPFINAL DISPOSITION PROCESSED—
Jan 13, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 30, 2015CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 7, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 13, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 28, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 28, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 8, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 19, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 11, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2015ALIEASSIGNED TO LIE—
May 21, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 13, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 13, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 4, 2015RFNTREFUSAL PROCESSED BY IB—
Dec 16, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 16, 2014RFRRREFUSAL PROCESSED BY MPU—
Dec 16, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 12, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2014DOCKASSIGNED TO EXAMINER—
Dec 12, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 11, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance